This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19

Name: This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19
Published: 2020
License: Public Domain

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

coronavirus-infections sars-cov-2 vaccine

coronavirus infections, vaccine, covid-19, sars-cov-2, immunobiological medicine, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19

Related documents